Primary Job Title CEO Primary Organization 
Eliaz Therapeutics
Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn
Andrew joined Daktari with more than 20 years of experience leading strategic, financial, and operations teams in life sciences and technology companies, ranging from Fortune 50 to start-ups.
Previously, Andrew was a Partner at the life sciences advisory firm Center for Disease Analysis, where he built a CFO advisory practice.
Prior
experience includes 16 years with Merck, including roles as Senior Director, Global Scientific Strategy – Portfolio Management, Senior Director, Business & Research Integration, Business Director of Advanced Technologies and Oncology, and Associate Director of Investment Analysis and Planning within Merck’s Research division.
Andrew also held the position of CFO at Advanticom Corporation.
Prior to joining Merck, Andrew spent several years with three regional public accounting firms providing litigation support, management advisory, accounting, tax, and audit services to small and mid-sized companies.
Andrew received his MBA degree from Lehigh University, a BS degree in Accounting from Rutgers College of Business, and served in the United States Navy.
